Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Dalbavancin clinical trials
11 selected ClinicalTrials.gov records carrying the official matched intervention Dalbavancin (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
11 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 25 selected PubMed records and 6 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT00678106
PeptideScanner retained ClinicalTrials.gov record NCT00678106 at 2026-11-16T17:37:42.807Z. Its registry update date was 2009-10-12, and PeptideScanner's reviewed identity mapping was dalbavancin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- October 12, 2009
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01339091
PeptideScanner retained ClinicalTrials.gov record NCT01339091 at 2026-11-16T17:37:42.807Z. Its registry update date was 2014-01-31, and PeptideScanner's reviewed identity mapping was dalbavancin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- January 31, 2014
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01946568
PeptideScanner retained ClinicalTrials.gov record NCT01946568 at 2026-11-16T17:37:42.807Z. Its registry update date was 2015-06-23, and PeptideScanner's reviewed identity mapping was dalbavancin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- June 23, 2015
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Dalbavancin · 2026-09-15
ClinicalTrials.gov record NCT06810583
Recruiting at the retained observation.
Open attributed record →Dalbavancin · 2026-06-22
ClinicalTrials.gov record NCT05046860
Active, not recruiting at the retained observation.
Open attributed record →Dalbavancin · 2024-09-19
ClinicalTrials.gov record NCT02814916
Completed at the retained observation.
Open attributed record →Dalbavancin · 2022-09-21
ClinicalTrials.gov record NCT04959799
Completed at the retained observation.
Open attributed record →Dalbavancin · 2020-04-10
ClinicalTrials.gov record NCT02961764
Completed at the retained observation.
Open attributed record →Dalbavancin · 2020-01-18
ClinicalTrials.gov record NCT03233438
Completed at the retained observation.
Open attributed record →Dalbavancin · 2019-01-04
ClinicalTrials.gov record NCT02685033
Completed at the retained observation.
Open attributed record →Dalbavancin · 2018-09-28
ClinicalTrials.gov record NCT02127970
Completed at the retained observation.
Open attributed record →Dalbavancin · 2015-06-23
ClinicalTrials.gov record NCT01946568
Completed at the retained observation.
Open attributed record →Dalbavancin · 2014-01-31
ClinicalTrials.gov record NCT01339091
Completed at the retained observation.
Open attributed record →Dalbavancin · 2009-10-12
ClinicalTrials.gov record NCT00678106
Completed at the retained observation.
Open attributed record →